Oct 28, 2019 / 02:00PM GMT
Operator
Good morning. Welcome to the Hypera Pharma Third Quarter of 2019 Results Conference Call. We have Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, CFO; and IRO are here with us today. We would like to inform you that this event is being recorded. (Operator Instructions) We also would like to inform that statements during the conference may be considered forward-looking statements. Such statements are subject to known and unknown risks and uncertainties that could cause the company's actual results to differ materially from those set forward in the forward-looking statements.
I would like now to turn over to Mr. Breno Oliveira. Mr. Breno Oliveira, you have the floor.
Breno Toledo Pires de Oliveira - Hypera S.A. - CEO
Good morning. Welcome to our Q3 teleconference call. Before I start talking about the operational performance, let me give you an update of our independent committee. We are expected to conclude the project by year's end.
Let me move on to the operational portion on Slide 3. Our sell-out grew by 11% in Q3, about 10% for the second
Q3 2019 Hypera SA Earnings Call Transcript
Oct 28, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers